Biopharmaceuticals
Venture Capital
News Release - August 3, 2023
Kyverna Therapeutics Extends Series B Financing Round to $145 Million and Brings in New Investors
Source: Kyverna Therapeutics
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.